ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 8 for:    Acute Disseminated Encephalomyelitis
Previous Study | Return to List | Next Study

Management Of Acute Disseminating Encephalomyelitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03284801
Recruitment Status : Not yet recruiting
First Posted : September 15, 2017
Last Update Posted : September 15, 2017
Sponsor:
Information provided by (Responsible Party):
Marwa Alsaid Ahmed, Assiut University

Brief Summary:
Acute disseminated encephalomyelitis is an immune-mediated inflammatory demyelinating disease of the central nervous system, which is typically transitory and self-limiting. It is characterized by an acute or subacute encephalopathy with neurological deficits, and magnetic resonance imaging evidence of widespread demyelination that predominantly involves the white matter of the brain and spinal cord. In the absence of specific biological markers, the diagnosis of Acute disseminated encephalomyelitis is still based upon a combination of clinical and neuro imaging features and exclusion of diseases that mimic Acute disseminated encephalomyelitis

Condition or disease Intervention/treatment
Acute Disseminated Encephalomyelitis Other: management of acute disseminating encephalomyelitis

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Management of Acute Disseminated Encephalomyelitis in Neurology Unit of Assiut University Children Hospital
Estimated Study Start Date : January 2018
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : March 2019

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: management of acute disseminating encephalomyelitis
    clinical audit on management of acute disseminating encephalomyelitis


Primary Outcome Measures :
  1. clinical audit on management of acute disseminating encephalomyelitis [ Time Frame: within one year ]

    To improve diagnosis and management of acute disseminated encephalomyelitis in Neurology Unit of Assiut University Children Hospital and to decrease the mortality and residual deficits from this disease.

    The aim of this audit is to measure the current practice within the Neurology Unit of Assiut University Children Hospital team in the diagnosis and management of acute disseminated encephalomyelitis against the recommendations in American Academy of Neurology guidance by using checklist and designed questionnaire.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Months to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
- All patient presented with manifestation of acute disseminating encephalomyelitis admitted in Assiut University Children Hospital
Criteria

Inclusion Criteria:

  • All patient presented with manifestation of acute disseminating encephalomyelitis admitted in Assiut University Children Hospital

Exclusion Criteria:

  • Patients presented with viral encephalitis,bacterial meningitis
  • Cases not fulfilling MRI criteria for diagnosis of acute disseminated encephalomyelitis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03284801


Contacts
Contact: Farouk Alsayed hassanen, prof 01006178123 Farouk.hassan@med.eu.edu.eg
Contact: Eman Fath Allah, Lecturer 01115191158 Fathalaeman@yahoo.com

Sponsors and Collaborators
Assiut University
Investigators
Principal Investigator: Marwa Alsaid Ahmed, resident doctor Assiut University

Publications:

Responsible Party: Marwa Alsaid Ahmed, Principle Investigator, Assiut University
ClinicalTrials.gov Identifier: NCT03284801     History of Changes
Other Study ID Numbers: ADEM
First Posted: September 15, 2017    Key Record Dates
Last Update Posted: September 15, 2017
Last Verified: September 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Encephalomyelitis
Encephalomyelitis, Acute Disseminated
Central Nervous System Infections
Central Nervous System Diseases
Nervous System Diseases
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Leukoencephalopathies
Brain Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases